• Pharmacogenomic Test

    Pharmacogenomic Test An assay intended to study inter-individual variations in whole genome or candidate gene, single nucleotide polymorphism SNP maps, haplotype markers, or alterations in gene expression or inactivation that may be correlated with pharmacological function and therapeutic response. In some cases, the pattern or profile of change is the relevant biomarker, rather than changes in individual markers. Pharmacogenomic testing provides information about a patient’s likelihood to have an adverse response and/or a therapeutic response to a medication, enabling the potential for a tailored and personalized approach to medication therapy. Although the primary focus of pharmacogenomic testing has been on improving drug selection and dosing in patient populations or individuals, a secondary potential benefit of testing may be the improvement of medication adherence.

← Back to Glossary

 

Know what medicines work for you. OnlyYOU is the only way to test your unique genetic makeup to see how you respond to medicinal cannabis.
Order Now